Eczema Clinical Trials

33 recruiting

Eczema Trials at a Glance

28 actively recruiting trials for eczema are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Bethesda, Gentofte Municipality, and Montreal. Lead sponsors running eczema studies include NAOS Les Laboratoires, Pfizer, and Professor Klaus Bønnelykke.

Browse eczema trials by phase

Treatments under study

About Eczema Clinical Trials

Looking for clinical trials for Eczema? There are currently 33 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Eczema trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Eczema clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting
Phase 2

Effects of Treatments on Atopic Dermatitis

DermatitisEczemaSkin Diseases, Genetic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)130 enrolled1 locationNCT01631617
Recruiting

Characterization of Chronic Hand Eczema

Atopic DermatitisChronic Hand Eczema
Dr. Robert Bissonnette270 enrolled1 locationNCT05026554
Recruiting

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

Atopic DermatitisEczema
National Human Genome Research Institute (NHGRI)530 enrolled1 locationNCT00605878
Recruiting
Phase 3

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Eczema
Pfizer150 enrolled40 locationsNCT06807268
Recruiting

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Atopic DermatitisHidradenitis SuppurativaAcne+3 more
Innovaderm Research Inc.500 enrolled1 locationNCT05994976
Recruiting
Not Applicable

Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

Eczema
USMARI Research & Innovation Centre15 enrolled1 locationNCT07463079
Recruiting
Phase 1

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

EczemaAtopic Dermatitis (AD)
Arcutis Biotherapeutics, Inc.125 enrolled1 locationNCT07453602
Recruiting
Not Applicable

Flourish: Exploring the Early Infant Gut Microbiome

MicrobiotaMicrobiomeGut Microbiome+1 more
Seeding Inc250 enrolled1 locationNCT07333482
Recruiting
Phase 2

Cardamom and Topical Roseomonas in Atopic Dermatitis

Atopic DermatitisEczema
National Institute of Allergy and Infectious Diseases (NIAID)120 enrolled1 locationNCT06096857
Recruiting
Phase 2

A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)

Atopic DermatitisEczema Atopic DermatitisEczema
Turn Therapeutics100 enrolled1 locationNCT07355075
Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

Atopic DermatitisEczema
Pfizer183 enrolled30 locationsNCT05689151
Recruiting
Phase 3

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06560255
Recruiting
Phase 3

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06570889
Recruiting
Not Applicable

Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters

DermatitisDermatitis, ContactDermatitis, Chronic+2 more
Biokosmes Srl90 enrolled3 locationsNCT07056569
Recruiting

Sodium in the Skin and Atopic Dermatitis

Atopic DermatitisEczema
University of California, San Francisco90 enrolled2 locationsNCT06998446
Recruiting
Phase 2

LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)

AllergyEczema
The University of New South Wales100 enrolled1 locationNCT06584552
Recruiting
Not Applicable

Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis

Atopic DermatitisEczema
NAOS Les Laboratoires64 enrolled1 locationNCT06930365
Recruiting
Not Applicable

Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.

Atopic DermatitisEczema, Atopic
NAOS Argentina S.A.100 enrolled3 locationsNCT05575882
Recruiting
Not Applicable

Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics

Hand Eczema
Fondazione Policlinico Universitario Agostino Gemelli IRCCS40 enrolled1 locationNCT06884163
Recruiting

A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis

Atopic DermatitisEczema
Almirall, S.A.1,000 enrolled1 locationNCT06815380